These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 23707305)

  • 1. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency.
    Thompson K; Flynn J; Okamura D; Zhou L
    J Ren Nutr; 2013 Sep; 23(5):333-9. PubMed ID: 23707305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal formulas pretreated with medications alters the nutrient profile.
    Taylor JM; Oladitan L; Carlson S; Hamilton-Reeves JM
    Pediatr Nephrol; 2015 Oct; 30(10):1815-23. PubMed ID: 25930981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate.
    Lee J; Moffett BS
    Pediatr Nephrol; 2016 Nov; 31(11):2113-7. PubMed ID: 27215929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.
    Georgianos PI; Liampas I; Kyriakou A; Vaios V; Raptis V; Savvidis N; Sioulis A; Liakopoulos V; Balaskas EV; Zebekakis PE
    Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional management of hyperkalemic infants with chronic kidney disease, using adult renal formulas.
    Hobbs DJ; Gast TR; Ferguson KB; Bunchman TE; Barletta GM
    J Ren Nutr; 2010 Mar; 20(2):121-6. PubMed ID: 19853475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.
    Lepage L; Dufour AC; Doiron J; Handfield K; Desforges K; Bell R; Vallée M; Savoie M; Perreault S; Laurin LP; Pichette V; Lafrance JP
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2136-42. PubMed ID: 26576619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study.
    Hagan AE; Farrington CA; Wall GC; Belz MM
    Clin Nephrol; 2016 Jan; 85(1):38-43. PubMed ID: 26587776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compared effects of calcium and sodium polystyrene sulfonate on mineral and bone metabolism and volume overload in pre-dialysis patients with hyperkalemia.
    Nakayama Y; Ueda K; Yamagishi SI; Sugiyama M; Yoshida C; Kurokawa Y; Nakamura N; Moriyama T; Kodama G; Minezaki T; Ito S; Nagata A; Taguchi K; Yano J; Kaida Y; Shibatomi K; Fukami K
    Clin Exp Nephrol; 2018 Feb; 22(1):35-44. PubMed ID: 28421299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional delivery in infants with CKD: techniques to avoid hyperkalemia.
    Bunchman TE
    J Ren Nutr; 2013 Sep; 23(5):387-8. PubMed ID: 23706704
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia.
    Kessler C; Ng J; Valdez K; Xie H; Geiger B
    J Hosp Med; 2011 Mar; 6(3):136-40. PubMed ID: 21387549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety analysis of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on rapid reduction of potassium in moderate to severe hyperkalemia patients with chronic kidney disease without dialysis.
    Fu X; Zhang S; Gao F; Mao N
    Clin Nephrol; 2024 Oct; 102(4):223-231. PubMed ID: 38994592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment of infant formula with sodium polystyrene sulfonate : focus on optimal amount and contact time.
    Cameron JC; Kennedy D; Feber J; Wong E; Geier P; Vaillancourt R
    Paediatr Drugs; 2013 Feb; 15(1):43-8. PubMed ID: 23329388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia.
    Mistry M; Shea A; Giguère P; Nguyen ML
    Ann Pharmacother; 2016 Jun; 50(6):455-62. PubMed ID: 27048188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineral content of infant formula after treatment with sodium polystyrene sulfonate or calcium polystyrene sulfonate.
    Fassinger N; Dabbagh S; Mukhopadhyay S; Lee DY
    Adv Perit Dial; 1998; 14():274-7. PubMed ID: 10649740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infant feeding practices.
    Marlin DW; Picciano MF; Livant EC
    J Am Diet Assoc; 1980 Dec; 77(6):668-76. PubMed ID: 7440862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium polystyrene sulfonate resin candy for control of potassium in chronic dialysis patients.
    Johnson K; Cazee C; Gutch C; Ogden D
    Clin Nephrol; 1976 Jun; 5(6):266-8. PubMed ID: 1277599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium polystyrene sulfonate used to reduce the potassium content of a high-protein enteral formula: a quantitative analysis.
    Rivard AL; Raup SM; Beilman GJ
    JPEN J Parenter Enteral Nutr; 2004; 28(2):76-8. PubMed ID: 15080600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.
    Davidson JP; King AJ; Kumaraswamy P; Caldwell JS; Korner P; Blanks RC; Jacobs JW
    J Cardiovasc Pharmacol Ther; 2018 May; 23(3):244-253. PubMed ID: 29130735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salbutamol versus cation-exchange resin (kayexalate) for the treatment of nonoliguric hyperkalemia in preterm infants.
    Yaseen H; Khalaf M; Dana A; Yaseen N; Darwich M
    Am J Perinatol; 2008 Mar; 25(3):193-7. PubMed ID: 18425722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hyperkalemia in hospitalized patients.
    Fordjour KN; Walton T; Doran JJ
    Am J Med Sci; 2014 Feb; 347(2):93-100. PubMed ID: 23255245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.